|
Volumn 89, Issue 15, 2015, Pages 7446-7448
|
Rethinking the response to emerging microbes: Vaccines and therapeutics in the Ebola Era-A conference at Harvard Medical School
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE DERIVATIVE;
ADENOVIRUS VECTOR;
EBOLA VACCINE;
MONOCLONAL ANTIBODY;
POXVIRUS VECTOR;
VIRUS FUSION INHIBITOR;
VIRUS VACCINE;
AFRICA;
ARTICLE;
DRUG INDUSTRY;
DRUG RESEARCH;
EBOLA HEMORRHAGIC FEVER;
EBOLAVIRUS;
EPIDEMIC;
FLUID THERAPY;
INFECTION CONTROL;
MEDICAL RESEARCH;
POST EXPOSURE PROPHYLAXIS;
PRIORITY JOURNAL;
SURVIVAL RATE;
TEAMWORK;
UNITED STATES;
COMMUNICABLE DISEASES, EMERGING;
CONSENSUS DEVELOPMENT;
GENETICS;
HEMORRHAGIC FEVER, EBOLA;
HUMAN;
IMMUNOLOGY;
VIROLOGY;
EBOLA VIRUS;
COMMUNICABLE DISEASES, EMERGING;
EBOLAVIRUS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
VIRAL VACCINES;
|
EID: 84937700501
PISSN: 0022538X
EISSN: 10985514
Source Type: Journal
DOI: 10.1128/JVI.01251-15 Document Type: Article |
Times cited : (6)
|
References (4)
|